Katherine Regling, D.O.

Hematology/Oncology

Katherine-Regling

Provider Name: Katherine Regling, D.O.

Academic Appointment: Assistant Professor of Pediatrics

Provider Specialty: Hematology/Oncology

Areas of Clinical Focus:  Benign Hematology/Hemostasis/Thrombosis

Areas of Research/Scholarship Focus:  Hemostasis/Thrombosis

Board Certification(s):  Pediatrics/Pediatric Hematology/Oncology

Primary Practice Name:

Primary Practice Address:

City: Detroit

State: MI

ZIP Code:

Practice Phone Number:

Practice Fax:

Other Practicing Locations:

Accepted Insurance: We accept most types on insurance. Please call to confirm that your carrier is on our list.

Languages Spoken:  English

Medical School:  Lake Erie College of Osteopathic Medicine

Internship:  Children's Hospital of MI/Henry Ford Hospital

Residency: Children's Hospital of MI

Fellowship: Children's Hospital of MI

Selected Publications:

[1]Regling K, Callaghan MU, Sidonio Jr. R. Managing Severe Hemophilia A in Children: Pharmacotherapeutic Options. Pediatric Health Med Ther. Invited review, accepted for publication – January 2022.

[2]Regling K, Saini A, Cashen K. Viscoelastic Testing in Pediatric Mechanical Circulatory Support. Frontiers in Medicine. Invited review, accepted for publication.

[3]Guzzardo G and Regling K. Developmental Hemostasis: The Evolution of Our Coagulation System. NeoReviews – Accepted for publication, January 2022.

[4]Bagla S, Regling K, Wakeling E, Gadgeel M, Buck S, Zaidi A, Flore L, Chicka M, Schiffer C, Chitlur M, Ravindranath Y. Distinctive phenotypes in two children with novel germline RUNX1 mutations – one with myeloid malignancy and increased fetal hemoglobin. Pediatr Hematol Oncol. 2020.

[5]Regling K, Pomerantz D, Narayanan S, Altinok D, Sivaswamy L, Marupudi N, Callaghan MU, Martin A. Reversible Cerebral Vasoconstriction Syndrome and Sickle Cell Disease: A Case Report. J Pediatr Hematol Oncol. 2019.

[6]Regling K, Callaghan MU, Rajpurkar M. Bivalirudin during thrombolysis with catheter-directed tPA in a heparin-refractory patient: A Case report. Pediatr Blood Cancer. 2019;e28094.

[7]Shatara M, Regling K, Sabo C, Figueroa M, Taub JW, Rajpurkar M. Ethosuximide-induced Thrombocytopenia: A Case Report. J Pediatr Hematol Oncol. 2019 Jul;41(5):420-421.

[8]Regling K, Kakulavarapu S, Thomas R, Hollon W, Chitlur MB. Utility of thromboelastography for the diagnosis of von Willebrand disease. Pediatr Blood Cancer. 2019 Jul;66(7):e27714.

Awards/Honors:

Share by: